An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread
Clinical trial NCT02832167 · COMPLETED
Trial details
- NCT number
- NCT02832167
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2019-10-20
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.